Once-Weekly Somapacitan as an Alternative Management of Growth Hormone Deficiency in Prepubertal Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
Growth hormone treatment has effectively restored normal growth in children with growth hormone deficiency (GHD); however, it poses challenges in compliance with a daily growth hormone injection regimen, leading to low adherence and persistence rates. Once-weekly Somapacitan is a potential alternati...
Main Authors: | Ghina Tsurayya, Cut Alifiya Nazhifah, Muhammad Rahmat Pirwanja, Putri Oktaviani Zulfa, Muhammad Raihan Ramadhan Tatroman, Fajar Fakri, Muhammad Iqhrammullah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/11/2/227 |
Similar Items
-
The role of asprosin and ceramides in the development of growth hormone deficiency in children
by: Muntadher Mohammad Al-Jubawi, et al.
Published: (2022-01-01) -
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan
by: Miller BS, et al.
Published: (2024-02-01) -
Editorial: New Insights and Controversies in Diagnosis and Treatment of Adult Growth Hormone Deficiency
by: Antonio Mancini, et al.
Published: (2022-01-01) -
Identifying patient-related predictors of permanent growth hormone deficiency
by: Veronica Mericq, et al.
Published: (2023-10-01) -
Long-Term Safety of Growth Hormone Deficiency Treatment in Cancer and Sellar Tumors Adult Survivors: Is There a Role of GH Therapy on the Neoplastic Risk?
by: Carolina Di Somma, et al.
Published: (2023-01-01)